Blackrock Operating Cash Flow decreased by 143.0% to -$980.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.1%, from -$1.13B to -$980.00M. Over 2 years (FY 2022 to FY 2025), Operating Cash Flow shows a downward trend with a -11.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.24B | $1.24B | $1.24B | $1.24B | $2.00B | -$408.00M | $1.37B | $1.38B | $2.62B | -$1.13B | $1.36B | $1.41B | $2.28B | -$980.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +61.3% | -120.4% | +434.6% | +1.2% | +89.6% | -143.1% | +220.9% | +3.7% | +61.0% | -143.0% |
| YoY Change | — | — | — | — | +61.3% | — | — | — | +31.0% | -176.5% | -0.1% | +2.4% | -13.0% | +13.1% |